Satellos Bioscience Inc.
MSCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $97 | $37 | $8,290 | $24,652 |
| - Cash | $57,659 | $22,067 | $1,924 | $4,871 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$57,562 | -$22,030 | $6,367 | $19,781 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$20 | -$9 | -$337 | -$120 |
| % Margin | – | – | – | – |
| EBITDA | -$28 | -$15 | -$8,070 | -$4,571 |
| % Margin | – | – | – | – |
| Net Income | -$28 | -$16 | -$11,322 | -$15,506 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.18 | -0.32 | -0.64 |
| % Growth | -33.3% | 43.8% | 50% | – |
| Operating Cash Flow | -$24,975 | -$14,501 | -$5,713 | -$5,034 |
| Capital Expenditures | -$6 | -$18 | -$3 | -$7 |
| Free Cash Flow | -$24,981 | -$14,519 | -$5,717 | -$5,041 |